Pentavalent vaccine makes a difference in Madagascar

in page functions

Madagascar shows benefits of health interventions with an impressive reduction of its under-five mortality rate

Madagascar - © GAVI/2011/Ed Harris

Doctor Hanintsoa Rakotoarimanga checks a mother’s immunisation record before giving the pentavalent vaccine at a health point in Isotry, a district of Madagascar’s capital, Antananarivo.

Madagascar is one of just seven countries that managed to reduce its under-five mortality rate by more than 60% over the 20-year period, 1990–2009. 

This shows that even in the most difficult of circumstances, immunisation and other basic interventions can play key roles in preventing disease and saving lives. 

According to Dr Rakotoarimanga, the pentavalent vaccine is having an impressive impact in Madagascar. “Since we started to use the pentavalent vaccine, we have seen much fewer cases of pneumonia and meningitis,” she says.

The price of the pentavalent vaccine has consistently become more affordable since 2007, when most GAVI-supported countries switched over to this five-in-one vaccine.

US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

More facts...

close icon

modal window here